AAAAAA

   
Results: 1-9 |
Results: 9
Reduced-intensity conditioning reduces the risk of severe infections afterallogeneic peripheral blood stem cell transplantation
Authors: Martino, R Caballero, MD Canals, C San Miguel, J Sierra, J Rovira, M Solano, C Bargay, J Perez-Simon, J Leon, A Sarra, J Brunet, S de la Camara, R
Citation: R. Martino et al., Reduced-intensity conditioning reduces the risk of severe infections afterallogeneic peripheral blood stem cell transplantation, BONE MAR TR, 28(4), 2001, pp. 341-347
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)
Authors: Bjorkstrand, B Svensson, H Goldschmidt, H Ljungman, P Apperley, J Mandelli, F Marcus, R Boogaerts, M Alegre, A Remes, K Cornelissen, JJ Blade, J Lenhoff, S Iriondo, A Carlson, K Volin, L Littlewood, T Goldstone, AH San Miguel, J Schattenberg, A Gahrton, G
Citation: B. Bjorkstrand et al., Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT), BONE MAR TR, 27(5), 2001, pp. 511-515
Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients
Authors: Casassus, P Gibson, J Joshua, DE Matthews, J Diaz, JC Gertz, MA Kyle, R Leong, T Oken, MM Fritz, E Ludwig, H Corrado, C Lastiri, F Peest, D Grosbois, B Vela-Ojeda, J Avvisati, G Mandelli, F Petrucci, MT Capnist, G Child, JA Drayson, MT Dunn, J MacLennan, I Mellstedt, H Osterborg, A Rodjer, S Turesson, I Westin, J Bergsagel, D Browman, GP Shustik, C Zee, B Hjorth, M Holmberg, E Rodjer, S Turesson, I Westin, J Alison, R Clarke, M Elphinstone, P Evans, V Gray, R Hicks, C James, S MacKinnon, L Peto, R Richards, S Wheatley, K Blade, J Fontanillas, M San Miguel, J Aitchison, R Newland, AC Cunningham, D Malpas, J Powles, RL Montuoro, A Jacobson, J Salmon, S
Citation: P. Casassus et al., Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients, BR J HAEM, 113(4), 2001, pp. 1020-1034
Two new 3 ' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemia
Authors: Chillon, MC Gonzalez, M Garcia-Sanz, R Balanzategui, A Gonzalez, D Lopez-Perez, R Mateos, MV Alaejos, I Rayon, C Arbeteta, J Hernandez, JM Orfao, A San Miguel, J
Citation: Mc. Chillon et al., Two new 3 ' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemia, GENE CHROM, 27(1), 2000, pp. 35-43
Detection of inv(16) and t(16;16) by fluorescence in situ hybridization inacute myeloid leukemia M4Eo
Authors: Hernandez, JM Gonzalez, MB Granada, I Gutierrez, N Chillon, C Ramos, F Ribera, JM Gonzalez, M Feliu, E San Miguel, J
Citation: Jm. Hernandez et al., Detection of inv(16) and t(16;16) by fluorescence in situ hybridization inacute myeloid leukemia M4Eo, HAEMATOLOG, 85(5), 2000, pp. 481-485
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
Authors: de Botton, S Chevret, S Sanz, M Dombret, H Thomas, X Guerci, A Fey, M Rayon, C Huguet, F Sotto, JJ Gardin, C Makhoul, PC Travade, P Solary, E Fegueux, N Bordessoule, D San Miguel, J Link, H Desablens, B Stamatoullas, A Deconinck, E Geiser, K Hess, U Maloisel, F Castaigne, S Preudhomme, C Chomienne, C Degos, L Fenaux, P
Citation: S. De Botton et al., Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial, BR J HAEM, 111(3), 2000, pp. 801-806
Conditioning regimens in autologous stem cell transplantation for multiplemyeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple Myeloma
Authors: Lahuerta, JJ Martinez-Lopez, J Grande, C Blade, J de la Serna, J Alegre, A Garcia-Larana, J Caballero, D Sureda, A de la Rubia, J Alvarez, AM Marin, J Escudero, A Conde, E Perez-Equiza, K Ruiz, JCG Moraleda, JM Leon, A Bargay, J Cabrera, R Hernandez-Garcia, MT Diaz-Mediavilla, J San Miguel, J
Citation: Jj. Lahuerta et al., Conditioning regimens in autologous stem cell transplantation for multiplemyeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple Myeloma, BR J HAEM, 109(1), 2000, pp. 138-147
Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery
Authors: del Canizo, MC Lopez, N Vazquez, L Fernandez, ME Brufau, A Caballero, MD Amigo, ML Mateos, MV Gutierrez, N San Miguel, J
Citation: Mc. Del Canizo et al., Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery, HAEMATOLOG, 84(6), 1999, pp. 511-516
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia
Authors: Fenaux, P Chastang, C Chevret, S Sanz, M Dombret, H Archimbaud, E Fey, M Rayon, C Huguet, F Sotto, JJ Gardin, C Makhoul, PC Travade, P Solary, E Fegueux, N Bordessoule, D San Miguel, J Link, H Desablens, B Stamatoullas, A Deconinck, E Maloisel, F Castaigne, S Preudhomme, C Degos, L
Citation: P. Fenaux et al., A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia, BLOOD, 94(4), 1999, pp. 1192-1200
Risultati: 1-9 |